These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20381105)

  • 1. Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer.
    Queiroga FL; Pérez-Alenza D; Silvan G; Peña L; Lopes CS; Illera JC
    Res Vet Sci; 2010 Dec; 89(3):396-403. PubMed ID: 20381105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours.
    Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes CS; Illera JC
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):76-82. PubMed ID: 18367392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of growth hormone excess in dogs with the progesterone receptor antagonist aglépristone.
    Bhatti SF; Duchateau L; Okkens AC; Van Ham LM; Mol JA; Kooistra HS
    Theriogenology; 2006 Sep; 66(4):797-803. PubMed ID: 16497368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.
    Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F
    Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications.
    Queiroga FL; Pérez-Alenza D; González-Gil A; Silván G; Peña L; Illera JC
    Reprod Domest Anim; 2015 Oct; 50(5):858-65. PubMed ID: 26332137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
    de Las Mulas JM; Millán Y; Dios R
    Vet Pathol; 2005 Mar; 42(2):200-12. PubMed ID: 15753474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.
    Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Balivo F; Piccolo P; Di Somma C; Colao A; Andria G
    J Pediatr; 2010 Apr; 156(4):663-70.e1. PubMed ID: 20022338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of steroid hormones and prolactin in canine mammary cancer.
    Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):181-7. PubMed ID: 15862964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.
    Yang XF; Beamer WG; Huynh H; Pollak M
    Cancer Res; 1996 Apr; 56(7):1509-11. PubMed ID: 8603394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.
    Sancak B; Coskun U; Gunel N; Onuk E; Cihan A; Karamercan A; Yildirim Y; Ozkan S
    Intern Med J; 2004 Jun; 34(6):310-5. PubMed ID: 15228391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
    Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
    Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration.
    Prahalada S; Block G; Handt L; DeBurlet G; Cahill M; Hoe CM; van Zwieten MJ
    Horm Metab Res; 1999; 31(2-3):133-7. PubMed ID: 10226793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken.
    Vasilatos-Younken R; Dunnington EA; Siegel PB; McMurtry JP
    Gen Comp Endocrinol; 1997 Jan; 105(1):31-9. PubMed ID: 9000465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch.
    Bhatti SF; Rao NA; Okkens AC; Mol JA; Duchateau L; Ducatelle R; van den Ingh TS; Tshamala M; Van Ham LM; Coryn M; Rijnberk A; Kooistra HS
    Domest Anim Endocrinol; 2007 Oct; 33(3):294-312. PubMed ID: 16956744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.
    Rocha RL; Hilsenbeck SG; Jackson JG; VanDenBerg CL; Weng Cn; Lee AV; Yee D
    Clin Cancer Res; 1997 Jan; 3(1):103-9. PubMed ID: 9815544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.
    Queiroga FL; Perez-Alenza MD; González-Gil A; Silván G; Peña L; Illera JC
    Vet Comp Oncol; 2017 Jun; 15(2):383-390. PubMed ID: 26463704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.